These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 10895282

  • 1. [The effect of obesity on ovarian function. I. Serum insulin and insulin dependent protein concentrations in obese patients with polycystic ovary syndrome].
    Kinalski M, Kowalska I, Wołczyński S, Straczkowski M, Telejko B, Kinalska I, Szamatowicz M.
    Ginekol Pol; 1999 Jun; 70(6):419-26. PubMed ID: 10895282
    [Abstract] [Full Text] [Related]

  • 2. [The influence of obesity on ovarian function. II. Plasma leptin concentration in women with polycystic ovary syndrome].
    Kowalska I, Kinalski M, Wołczyński S, Straczkowski M, Kinalska I, Szamatowicz M.
    Ginekol Pol; 1999 Jun; 70(6):428-32. PubMed ID: 10895283
    [Abstract] [Full Text] [Related]

  • 3. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V, Barash A, Shoham Z, Koistinen R, Seppala M, Hen M, Lunenfeld B, Zadik Z.
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [Abstract] [Full Text] [Related]

  • 4. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
    Olszanecka-Glinianowicz M, Banaś M, Zahorska-Markiewicz B, Kuglin D, Mokrzycka J, Mentel A.
    Endokrynol Pol; 2005 Jan; 56(6):921-6. PubMed ID: 16821212
    [Abstract] [Full Text] [Related]

  • 5. [Correlation between hormonal and metabolic profiles in women with polycystic ovary syndrome].
    Esposito V, Federico P, Lo Iudice G, Rispoli C, Sabatino P, D'Alessandro B.
    Minerva Endocrinol; 1992 Jan; 17(1):21-9. PubMed ID: 1495451
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome.
    Kowalska I, Kinalski M, Straczkowski M, Wolczyski S, Kinalska I.
    Eur J Endocrinol; 2001 May; 144(5):509-15. PubMed ID: 11331217
    [Abstract] [Full Text] [Related]

  • 8. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [Abstract] [Full Text] [Related]

  • 9. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.
    Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG.
    J Clin Endocrinol Metab; 1991 Jan; 72(1):83-9. PubMed ID: 1898744
    [Abstract] [Full Text] [Related]

  • 10. Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction.
    Hamilton-Fairley D, Kiddy D, Anyaoku V, Koistinen R, Seppälä M, Franks S.
    Clin Endocrinol (Oxf); 1993 Sep; 39(3):363-7. PubMed ID: 7693380
    [Abstract] [Full Text] [Related]

  • 11. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A, Mandeli J, Fluhr H, Dobrjansky A.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [Abstract] [Full Text] [Related]

  • 12. The effect of weight loss on inflammation in obese women with polycystic ovary syndrome.
    Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Kocełak P, Janowska J, Semik-Grabarczyk E.
    Endokrynol Pol; 2008 Jan; 59(1):13-7. PubMed ID: 18335395
    [Abstract] [Full Text] [Related]

  • 13. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.
    Slowinska-Srzednicka J, Zgliczynski W, Makowska A, Jeske W, Brzezinska A, Soszynski P, Zgliczynski S.
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1432-5. PubMed ID: 1534330
    [Abstract] [Full Text] [Related]

  • 14. Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome.
    Hamilton-Fairley D, White D, Griffiths M, Anyaoku V, Koistinen R, Seppälä M, Franks S.
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):159-65. PubMed ID: 7554310
    [Abstract] [Full Text] [Related]

  • 15. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.
    Pawelczyk L, Spaczynski RZ, Banaszewska B, Duleba AJ.
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr 15; 113(2):209-13. PubMed ID: 15063962
    [Abstract] [Full Text] [Related]

  • 16. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA, Kerimoglu OS, Pekin AT, Incesu F, Dogan NU, Celik C, Unlu A.
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep 15; 180():56-60. PubMed ID: 25020276
    [Abstract] [Full Text] [Related]

  • 17. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.
    Holte J, Bergh T, Berne C, Wide L, Lithell H.
    J Clin Endocrinol Metab; 1995 Sep 15; 80(9):2586-93. PubMed ID: 7673399
    [Abstract] [Full Text] [Related]

  • 18. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, Votsi E, Diamanti-Kandarakis E.
    Fertil Steril; 2006 Jun 15; 85(6):1778-83. PubMed ID: 16650418
    [Abstract] [Full Text] [Related]

  • 19. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
    Milewicz T, Krzysiek J, Janczak-Saif A, Sztefko K, Krzyczkowska-Sendrakowska M.
    Endokrynol Pol; 2005 Jun 15; 56(6):883-90. PubMed ID: 16821206
    [Abstract] [Full Text] [Related]

  • 20. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D, Farmakiotis D, Rousso D, Katsikis I, Delkos D, Piouka A, Gerou S, Diamanti-Kandarakis E.
    Eur J Intern Med; 2008 Oct 15; 19(6):406-12. PubMed ID: 18848173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.